drugset / Trial / NCT00189072

Effects of Gabapentin in the Treatment of Neuropathic Pain on Driving Performance and Cognition

NCT00189072

Phase 4 Terminated 24 enrolled UMC Utrecht Utrecht University · collab
RandomizedCrossoverDouble-blindTreatment

Summary

The aim of this study was to explore the effects of pain on the one hand and the effects of treatment of pain with gabapentin (900, 1200, 1800 or 2400 mg) on the other hand on actual driving performance and several laboratory tests in patients with neuropathic pain. It was hypothesized that gabapentin might influence performance after acute but not after subchronic administration.

Timeline

Start
2003-04
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 900 mg
Subject Gabapentin Small molecule 1200 mg
Subject Gabapentin Small molecule 1800 mg
Subject Gabapentin Small molecule 2400 mg

Indications